![]() |
Volumn 38, Issue 3, 2015, Pages e38-e39
|
Remission of severe neonatal diabetes with very early sulfonylurea treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLIBENCLAMIDE;
HEMOGLOBIN A1C;
INSULIN;
INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;
ANTIDIABETIC AGENT;
SULFONYLUREA DERIVATIVE;
CASE REPORT;
CHILD;
DRUG MEGADOSE;
DRUG WITHDRAWAL;
EARLY INTERVENTION;
FEMALE;
GENE MUTATION;
GLYCEMIC CONTROL;
HEMOGLOBIN BLOOD LEVEL;
HETEROZYGOSITY;
HUMAN;
HYPERGLYCEMIA;
KCNJ11 GENE;
MALE;
NECROTIZING ENTEROCOLITIS;
NEWBORN;
NEWBORN DIABETES MELLITUS;
NOTE;
PRESCHOOL CHILD;
REMISSION;
DIABETES MELLITUS;
DRUG ADMINISTRATION;
SEVERITY OF ILLNESS INDEX;
CHILD;
DIABETES MELLITUS;
DRUG ADMINISTRATION SCHEDULE;
EARLY MEDICAL INTERVENTION;
FEMALE;
GLYBURIDE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INFANT, NEWBORN;
INSULIN;
MALE;
REMISSION INDUCTION;
SEVERITY OF ILLNESS INDEX;
SULFONYLUREA COMPOUNDS;
|
EID: 84962428097
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc14-2124 Document Type: Note |
Times cited : (15)
|
References (5)
|